Schwäbische Zeitung: “SHS-Medizintechnikindex nimmt Branche unter die Lupe” (SHS Medical Technology Index takes a close look at the industry)
How has the medical technology industry developed in comparison to the overall economy in recent years? The Schwäbische Zeitung reports on the SHS Medical Technology Index.
Trend reversal: SHS Medical Technology Index points upwards again
SHS sees medical technology back on track for success in Germany in 2019 Medical technology sector increases turnover by 10% in 2019 In spite of COVID-19, SHS expects the medical technology industry to outperform the German economy as a whole in 2020 as well Effects of the EU Medical Device Regulation (MDR) not yet digested […]
Ärzteblatt: “NMR-Spektroskopie: Abstoßung ohne Biopsie erkennen” (NMR spectroscopy: detecting rejection without biopsy)
A real improvement in kidney transplant rejection diagnostics: The transplantation of a organ (e.g. kidney) is a highly invasive procedure, a high risk but also chance for the patient and a huge burden for the body to process. Furthermore, current standards of diagnosis for the rejection risk of transplanted kidneys are invasive, not robust, and an additonal burden for the patient. This is changing now by using NMR spectroscopy as a reliable and cost efficient non invasive alternative. Would it not be good to have access to such methodology as a standard?
medtech zwo: “MedtecLIVE Session: Finanzierung in der Medizintechnik”
At MedtecLIVE, which will take place virtually for the first time on 1 July, everything will revolve around the topic of financing in medical technology, with the aim of networking the players in the medical technology sector. The programme includes live streamed lectures, talks and pitches. Among others, SHS will also be present.
SHS appoints Heinz Jacqui Senior Advisor
Heinz Jacqui (59) has been appointed Senior Advisor at SHS Gesellschaft für Beteiligungsmanagement effective June 1, 2020. By way of succession arrangements or growth financing, SHS specializes in investing in innovative healthcare companies that focus on medical technology and the life sciences. Through several funds, SHS has more than EUR 300 million under management. It […]
Miracor Medical’s PiCSO® System receives CE Mark
Miracor Medical SA (Miracor Medical) has announced the award of the CE Mark for its latest generation of PiCSO Impulse Catheter and PiCSO Impulse Console, which is indicated for the treatment of anterior STEMI patients. The new system features improvements in ease of use.
AOT AG successfully completes all surgeries required for the first-in-man clinical study of the CARLO® device for laser-assisted cutting of human bones
CE marking is expected for 2020 Submission at the FDA is expected for early 2021 On June 19, 2020, the Swiss Medtech company Advanced Osteotomy Tools (AOT) successfully completed the last surgery required for the first-in-man clinical study of its proprietary CARLO® device. The aim of the study was to demonstrate the performance and safety […]
Frankfurter Allegmeine Zeitung: “Online-Hilfe für psychisch Kranke” (Online help for mentally ill people)
FAZ reports on the SHS portfolio company Selfapy, which offers online therapies for depression, anxiety and eating disorders. This enables patients who need acute help to bridge long waiting times until a doctor’s appointment.
Market study medical technology 2020 – with data on equity and M&A transactions
The M&A consultancy Clairfield and Luther Rechtsanwaltsgesellschaft prepared this informative study with the support of the German Medical Technology Association (BVMed) and the German Engineering Federation (VDMA). The study gives you an overview of the current development of medical technology in Germany, Europe, the USA and Asia: from a legal, technical and transaction-oriented perspective. Due […]
BVK Expert Talk: Dr. André Zimmermann: “Our investors pursue a socially responsible approach”
Dr. André Zimmermann, partner at SHS, was a guest in the BVK expert talk. Deputy Managing Director Swantje von Massenbach spoke to him about investments in the health sector, such as medical technology or diagnostics. Among other things, this included a rapid corona test that can achieve a result within 15 minutes with comparable accuracy to tests that still take several hours today. For portfolio companies and SHS investors, what is known as impact investing is particularly important. This means that investments have positive effects on health, the environment or society. You can learn more about this in the video.